pLVX-UbC-rtTA-Isl1_2A_Lhx3-BSD
(Plasmid
#226282)
-
PurposeTetracycline-inducible expression of Isl1 and Lhx3 for direct reprogramming of canine fibroblasts to induced-motor neurons
-
Depositing Lab
-
Sequence Information
Ordering
| Item | Catalog # | Description | Quantity | Price (USD) | |
|---|---|---|---|---|---|
| Plasmid | 226282 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $89 | |
Backbone
-
Vector backbonepLVX-tight-puro and pLVX-rtTA(advanced)
-
Backbone manufacturerClontech
- Backbone size w/o insert (bp) 9766
- Total vector size (bp) 11882
-
Modifications to backboneVector contains both the rtTA(advanced) derived from pLVX-rtTA(advanced) (Clontech) driven by the UbC promoter, as well as ISL1:T2A:LHX3 driven by the TREtight promoter
-
Vector typeMammalian Expression, Lentiviral
-
Selectable markersBlasticidin
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)NEB Stable
-
Copy numberUnknown
Gene/Insert
Cloning Information
- Cloning method Gibson Cloning
- 5′ sequencing primer TGG AGA AGG ATC CTG CCA CCA TGG GAG ACA TG
- 3′ sequencing primer GGT AGA ATT CAC TCC CTC GAG TTA GAA CTG AGC (Common Sequencing Primers)
Resource Information
-
A portion of this plasmid was derived from a plasmid made byFred Gage and Chun-Li Zhang.
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pLVX-UbC-rtTA-Isl1_2A_Lhx3-BSD was a gift from Susannah Sample (Addgene plasmid # 226282 ; http://n2t.net/addgene:226282 ; RRID:Addgene_226282) -
For your References section:
Protocol for direct reprogramming of canine fibroblasts to induced motor neurons. Anderson RS, Corona AC, Suzuki M, Sample SJ. STAR Protoc. 2025 Sep 19;6(3):103975. doi: 10.1016/j.xpro.2025.103975. Epub 2025 Jul 24. 10.1016/j.xpro.2025.103975 PubMed 40711874